Skip to content

ARSPHARMA

Active
Private limited companyfounded 201213 yrs activeAntwerpsesteenweg 281A, 2390 Malle, BelgiumKBO/BCE: BE 0849.745.437
Summary

ARSPHARMA has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €197,851 and a net result of €28,113. Equity is growing by ~15.7% per year across the filed fiscal years. Its solvency ranks better than 26% of 2028 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability73▲+2
Solvency49=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days acceptable
Liquidity short (current ratio 0.82 against 0.7 in 2024; short-term debt: 59.7% and cash: 12.9% of total assets), and 76.4% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 71
Relative position
BE, all sectors
reference
Architectural and engineering activities; technical testing and analysis (NACE 71)
about 56% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
23.6%
Return on assets
3.4%
Age of the figures
12 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 13 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-04-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
on the day
2023
2 d late
2022
2 d early
2021
1 d early
2020
91 d early
2019
90 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 26 days before the deadline; the sector median for financial year 2024 is 8 days before the deadline, and 33% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ARSPHARMA was incorporated on 12 October 2012.1 Total assets rose from EUR 446,107 in 2018 to EUR 839,146 in 2025 and headcount from 0.3 full-time equivalents in 2020 to 0.5 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2020 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€197,851▲ 16.6%
2024 · €169,738
Total assets
€839,146▲ 19.2%
2024 · €703,875
Net result
€28,113▲ 125%
2024 · €12,475
Working capital
-€92,498▲ 16.1%
2024 · -€110,296
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€27,942▼ 40.3%€8,752▼ 68.7%€53,742▲ 514%€25,051▼ 53.4%€65,010▲ 160%
Net result€14,014▼ 46.8%-€1,118€32,250€12,475▼ 61.3%€28,113▲ 125%
Equity€126,131▲ 12.5%€125,013▼ 0.9%€157,263▲ 25.8%€169,738▲ 7.9%€197,851▲ 16.6%
Total assets€872,010▼ 13.5%€775,262▼ 11.1%€847,696▲ 9.3%€703,875▼ 17.0%€839,146▲ 19.2%
Debt€745,879▼ 16.8%€650,249▼ 12.8%€690,433▲ 6.2%€534,137▼ 22.6%€641,295▲ 20.1%
Working capital€43,148▼ 85.0%€35,542▼ 17.6%€4,973▼ 86.0%-€110,296-€92,498▲ 16.1%
Staff (FTE)0.5▲ 66.7%0.5=0.5=0.5=0.5=
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
-€20,000€0€20,000€40,000€60,000Operating result 2021: €27,942€27,942Net result 2021: €14,014€14,014Operating result 2022: €8,752€8,752Net result 2022: -€1,118-€1,118Operating result 2023: €53,742€53,742Net result 2023: €32,250€32,250Operating result 2024: €25,051€25,051Net result 2024: €12,475€12,475Operating result 2025: €65,010€65,010Net result 2025: €28,113€28,11320212022202320242025€0€20,000€40,000€60,000Operating result 2023: €53,742€53,700Net result 2023: €32,250€32,300Operating result 2024: €25,051€25,100Net result 2024: €12,475€12,500Operating result 2025: €65,010€65,000Net result 2025: €28,113€28,100202320242025
The operating result recovers in 2025; 2025 is 160% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €839,146
Fixed assets €430,349 ▼ 2.5%
Current assets €408,797 ▲ 55.9%
Equity and liabilities €839,146
Equity €197,851 ▲ 16.6%
Debt €641,295 ▲ 20.1%
Debt's share of the balance-sheet total rises from 75.9% to 76.4%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€76,237▲
2024 · €35,236
Cash flow
€39,341▲
2024 · €22,659
Current ratio
0.82▲
2024 · 0.70
Debt to equity
3.24▲
2024 · 3.15
ROE
14.2%▲
2024 · 7.3%
ROA
3.4%▲
2024 · 1.8%
Interest coverage
6.11▼
2024 · 14.33
Debt ≤ 1 year
€501,295▲
2024 · €372,595
Debt > 1 year
€130,000▼
2024 · €161,542
Income taxes
€24,411▲
2024 · €10,154
Staff costs
€22,890▼
2024 · €28,703
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet Code20242025
Assets
Total assets20/58€703,875€839,146▲
Fixed assets21/28€441,576€430,349▼
Intangible fixed assets21-€0
Tangible fixed assets22/27€16,576€5,349▼
Furniture and vehicles24€6,804€5,349▼
Other tangible fixed assets26€9,772€0▼
Financial fixed assets28€425,000€425,000=
Current assets29/58€262,299€408,797▲
Amounts receivable within one year40/41€143,313€300,338▲
Trade receivables40€128,077€286,850▲
Other amounts receivable41€15,236€13,487▼
Cash at bank and in hand54/58€118,986€108,459▼
Equity and liabilities
Total equity and liabilities10/49€703,875€839,146▲
Equity10/15€169,738€197,851▲
Contributions10/11€6,300€6,300=
Reserves13€163,438€191,551▲
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€161,578€189,691▲
Amounts payable17/49€534,137€641,295▲
Amounts payable after more than one year17€161,542€130,000▼
Financial debts170/4€161,542€130,000▼
Amounts payable within one year42/48€372,595€501,295▲
Current portion of amounts payable after more than one year42€69,439€12,106▼
Trade debts44€266,459€459,241▲
Suppliers440/4€266,459€459,241▲
Advances received on contracts in progress46€357€357=
Taxes, remuneration and social security45€28,941€22,192▼
Taxes450/3€27,473€19,869▼
Remuneration and social security454/9€1,469€2,323▲
Other amounts payable47/48€7,400€7,400=
Accrued charges and deferred income492/3-€10,000
Income statement Code20242025
Non-recurring operating income76A-€66,116
Remuneration, social security and pensions62€28,703€22,890▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10,184€11,227▲
Other operating charges640/8€6,004€2,728▼
Gross operating margin9900€69,943€101,856▲
Operating profit (loss)9901€25,051€65,010▲
Financial income75/76B€36€1▼
Recurring financial income75€36€1▼
Financial charges65/66B€2,459€12,487▲
Recurring financial charges65€2,459€12,487▲
Profit (loss) for the period before taxes9903€22,628€52,524▲
Income taxes67/77€10,154€24,411▲
Profit (loss) for the period9904€12,475€28,113▲
Profit (loss) for the period to be appropriated9905€12,475€28,113▲
Appropriation of the result
Profit (loss) to be appropriated9906€12,475€28,113▲
Transfer to equity691/2€12,475€28,113▲
To other reserves6921€12,475€28,113▲
Social balance
Average headcount (FTE)90870.50.5=

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A----€66,116-
Remuneration, social security and pensions62€21,586€21,409€26,961€28,703€22,890▼ 20.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,772€9,772€9,772€10,184€11,227▲ 10.2%
Other operating charges640/8€1,076€587€1,932€6,004€2,728▼ 54.6%
Gross operating margin9900€60,376€40,521€92,408€69,943€101,856▲ 45.6%
Operating profit (loss)9901€27,942€8,752€53,742€25,051€65,010▲ 160%
Financial income75/76B€0€280€434€36€1▼ 98.3%
Recurring financial income75€0€280€434€36€1▼ 98.3%
Financial charges65/66B€7,860€8,929€4,711€2,459€12,487▲ 408%
Recurring financial charges65€7,860€8,929€4,711€2,459€12,487▲ 408%
Profit (loss) for the period before taxes9903€20,082€103€49,465€22,628€52,524▲ 132%
Income taxes67/77€6,068€1,221€17,215€10,154€24,411▲ 140%
Profit (loss) for the period9904€14,014-€1,118€32,250€12,475€28,113▲ 125%
Profit (loss) for the period to be appropriated9905€14,014-€1,118€32,250€12,475€28,113▲ 125%
Line20212022202320242025Change
Assets
Total assets20/58€872,010€775,262€847,696€703,875€839,146▲ 19.2%
Fixed assets21/28€464,090€454,317€444,545€441,576€430,349▼ 2.5%
Intangible fixed assets21----€0-
Tangible fixed assets22/27€39,090€29,317€19,545€16,576€5,349▼ 67.7%
Furniture and vehicles24---€6,804€5,349▼ 21.4%
Other tangible fixed assets26€39,090€29,317€19,545€9,772€0▼ 100%
Financial fixed assets28€425,000€425,000€425,000€425,000€425,000=
Current assets29/58€407,920€320,945€403,151€262,299€408,797▲ 55.9%
Amounts receivable within one year40/41€119,716€137,753€215,464€143,313€300,338▲ 110%
Trade receivables40€94,841€127,079€201,723€128,077€286,850▲ 124%
Other amounts receivable41€24,875€10,674€13,741€15,236€13,487▼ 11.5%
Cash at bank and in hand54/58€288,204€153,391€187,686€118,986€108,459▼ 8.8%
Deferred charges and accrued income490/1-€29,801----
Equity and liabilities
Total equity and liabilities10/49€872,010€775,262€847,696€703,875€839,146▲ 19.2%
Equity10/15€126,131€125,013€157,263€169,738€197,851▲ 16.6%
Contributions10/11€6,300€6,300€6,300€6,300€6,300=
Outside capital11€6,300€6,300€6,300---
Other1109/19€6,300€6,300€6,300---
Reserves13€119,831€118,713€150,963€163,438€191,551▲ 17.2%
Non-distributable reserves130/1€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860€1,860€1,860€1,860=
Distributable reserves133€117,971€116,853€149,103€161,578€189,691▲ 17.4%
Amounts payable17/49€745,879€650,249€690,433€534,137€641,295▲ 20.1%
Amounts payable after more than one year17€350,107€246,346€177,781€161,542€130,000▼ 19.5%
Financial debts170/4€350,107€246,346€177,781€161,542€130,000▼ 19.5%
Amounts payable within one year42/48€364,772€285,403€398,177€372,595€501,295▲ 34.5%
Current portion of amounts payable after more than one year42€59,383€70,230€68,565€69,439€12,106▼ 82.6%
Trade debts44€297,960€206,893€303,522€266,459€459,241▲ 72.3%
Suppliers440/4€297,960€206,893€303,522€266,459€459,241▲ 72.3%
Advances received on contracts in progress46---€357€357=
Taxes, remuneration and social security45€7,429€881€18,691€28,941€22,192▼ 23.3%
Taxes450/3€6,109€852€17,227€27,473€19,869▼ 27.7%
Remuneration and social security454/9€1,320€28€1,464€1,469€2,323▲ 58.2%
Other amounts payable47/48-€7,400€7,400€7,400€7,400=
Accrued charges and deferred income492/3€31,000€118,500€114,475-€10,000-
Line20212022202320242025Change
Profit (loss) for the period9904€14,014-€1,118€32,250€12,475€28,113▲ 125%
+ Depreciation and write-downs630€9,772€9,772€9,772€10,184€11,227▲ 10.2%
Operating cash flow (approximation)€23,786€8,654€42,023€22,659€39,341▲ 73.6%
Investment in fixed assets (approximation)-€0€0-€7,216€0▲ 100%
Change in cash--€134,814€34,296-€68,700-€10,527▲ 84.7%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
29-04
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-04
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
02-05
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 2 days late
2023
30-09
Financial Back to profitnet €32,250
Net result €32,250 after one loss-making year.
30-09
Financial Equity above €150,000Eq €157,263 ▲25.8%
Equity rises from €125,013 to €157,263.
28-04
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-04
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
29-01
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial Equity above €100,000Eq €112,117 ▲30.7%
2 profitable years in a row build equity to €112,117.
31-01
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-09
Financial Back to profitnet €75,345
Net result €75,345 after one loss-making year.
31-01
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
31-01
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
31-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Malle · 1 establishment unit since 2012
seat establishment The establishment unit on the map
Ground area
2,310 m²
Building footprint
1,399 m²
Volume, LiDAR
847 m³
Parcel 11049B0378/00K003, Flanders · tallest building 13.7 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
ARS INTERIORS
Antwerpsesteenweg 281A, 2390 MalleActivities of interior architects
since 20122.214.813.371
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11049B0378/00K003 Flanders 2,310 m² 1 · 1,399 m² 13.7 m
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

2 owners · 1 holding

Chain of control

  1. MDC-INTERIEUR 100%
  2. ARSPHARMA

Highest known parent: MDC-INTERIEUR. The sources do not say who stands above it.

Owners 2

Holdings 1

According to the annual accounts to 30-09-2025 of ARSPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Public money · subsidies and aid

Flemish government

2023 to 2025 · 2 entries · 1,344 EUR awarded · 1,344 EUR paid
Year Entries awardedpaid
2025 1 1,020 EUR1,020 EUR
2023 1 324 EUR324 EUR
Schemes
2 entries · 1,344 EUR · 1,344 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 3,924 companies in sector 71112 we hold annual accounts for 1,294. 960 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded12-10-2012
Fiscal year end30-09
Activities, NACEBEL 2025
71112Activities of interior architects
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0849745437
Also 9925:BE0849745437
Registered 27-05-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.